CHE - Guggenheim likes Sarepta in premarket analyst action November, 01 2019 07:07 AM Chemed Corp Axonics Modulation Technologies (NASDAQ:AXNX) initiated with Overweight rating at Piper Jaffray.More news on: Axonics Modulation Technologies, Inc., Homology Medicines, Inc., Sarepta Therapeutics, Inc., Healthcare stocks news, Stocks on the move, , Read more ...